Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06400264
What this trial is testing

Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT03049254
What this trial is testing

Mayo AVC Registry and Biobank

Who this might be right for
Arrhythmogenic Right Ventricular CardiomyopathyCardiomyopathiesHeart Diseases+14 more
Mayo Clinic 1,000
Not applicableWithdrawnNCT03205137
What this trial is testing

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Who this might be right for
Hypertension
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT02251717
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 114
Testing effectiveness (Phase 2)Study completedNCT01957202
What this trial is testing

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Who this might be right for
Rhinitis, Allergic, Perennial and Seasonal
GlaxoSmithKline 71
Early research (Phase 1)Study completedNCT05403281
What this trial is testing

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 41
Early research (Phase 1)Study completedNCT05874167
What this trial is testing

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 50
Early research (Phase 1)Study completedNCT05453786
What this trial is testing

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
SK Chemicals Co., Ltd. 51
Early research (Phase 1)Study completedNCT05428306
What this trial is testing

Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 42
Not applicableUnknownNCT03860454
What this trial is testing

The Deep Phenotype of Lamin A/C Cardiomyopathy

Who this might be right for
Lamin A/C Gene MutationDilated Cardiomyopathy, Familial
University College, London 150
Early research (Phase 1)Study completedNCT03078556
What this trial is testing

Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 154
Early research (Phase 1)Study completedNCT02045966
What this trial is testing

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 16
Early research (Phase 1)Study completedNCT02094924
What this trial is testing

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

Who this might be right for
Hypertension
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Early research (Phase 1)Study completedNCT01344629
What this trial is testing

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

Who this might be right for
Healthy
Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT01508182
What this trial is testing

Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 64
Early research (Phase 1)Study completedNCT03005782
What this trial is testing

Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers

Who this might be right for
Malignancies
Regeneron Pharmaceuticals 333
Early research (Phase 1)Study completedNCT05498480
What this trial is testing

Study of Relatlimab in Combination With Nivolumab in Chinese Participants

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 6
Post-approval studies (Phase 4)Ended earlyNCT04040075
What this trial is testing

Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy

Who this might be right for
HIV-1-infection
Southampton Healthcare, Inc. 12
Early research (Phase 1)Study completedNCT05078593
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma

Who this might be right for
Solid Tumor, AdultLymphoma
Shanghai Henlius Biotech 18
Next Page